Contact Information
|
Kevin Claffey, Ph.D.
Center for Vascular Biology
University of Connecticut Health Center
263 Farmington Avenue
Farmington, CT 06030-3501
Phone: 860-679-8713
Fax: 860-679-1201
Email:
claffey@nso2.uchc.edu |
Claffey Lab
Mechanisms of tumor angiogenesis mediated by
hypoxia-induced vascular endothelial growth factor
expression. Tumor cell regulation of VEGF transcriptional,
post-transcriptional and translation under hypoxia. Cellular
mRNA binding proteins facilitating VEGF expression. Tumor
microenvironmental factors that modulate the balance between
positive and negative angiogenic factors.
Role of membrane-type matrix metalloproteinases in breast
cancer invasion and metastasis. Control of MT-MMP gene
expression by tumor microenvironments mediated by cytokine,
hypoxia and metabolic byproducts. MT-MMP activation cascades
regulated by post-translational mechanisms.
[back to top]
- Identification of mRNA binding
proteins that regulate VEGF mRNA
stability under hypoxia. Determination
of mRNA binding protein expression
profiles in tumor cells with
differential sensitivities to hypoxia
with respect to VEGF expression.
Defining signaling mechanisms which
control the cellular distribution and
activity of VEGF mRNA binding proteins
activated under hypoxic conditions.
- Evaluation of breast cancer
molecular mechanisms controlling MT1-MMP
expression. These include estrogen
receptor expression, genomic methylation,
transcription factor expression and
activation, signal transduction pathways
and loss of tumor suppressor activity.
- Clinical translational breast,
melanoma and colon cancer projects
characterizing patient-specific immune
response to tumor. Molecular
characterization of self-reactive
antigens reflected by local lymph node
activation.
[back to top]
The following methods are used by our
lab:
- Histological Methods
- In Vivo Angiogenesis using Matrigel
Implants
- In Vivo Microvascular Permeability
Assays
- Production of Chicken IgY Polyclonal
Antibodies
[back to top]
|